Theradaptive

Mar 17, 2025

Theradaptive Welcomes Jeffrey W. Dunn to its Board of Directors

Dec 10, 2024

Theradaptive Obtains FDA IDE Approval to Study OsteoAdapt(TM) SP in Additional Spinal Fusion Indications

Nov 06, 2024

Theradaptive Announces Peer-Reviewed Publication in Spine of Preclinical Spinal Fusion Study of OsteoAdapt(TM) SP

Feb 01, 2024

U.S. FDA GRANTS THERADAPTIVE IDE APPROVAL FOR PHASE I/II CLINICAL TRIALS